Skip to content

Opening book details…

About this Medicine article

5ICCN_037: Cost effectiveness of palivizumab for RSV prevention in high-risk infants for the 2012/2013 epidemic season in Moscow by Soldatova, I.; Ignatyeva, V.; Avksentyeva, M.; Rebrova, O.; Gerasimova, K.; Asmolova, G.; Pankratyeva, L.; Degtyareva, E.; Ovsyannikov, D. is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
Soldatova, I.; Ignatyeva, V.; Avksentyeva, M.; Rebrova, O.; Gerasimova, K.; Asmolova, G.; Pankratyeva, L.; Degtyareva, E.; Ovsyannikov, D.
Publisher
Elsevier Science; Elsevier ; Elsevier BV (ISSN 0378-3782)
Published
2014
Field
Medicine (Health Sciences)

More by Soldatova, I.; Ignatyeva, V.; Avksentyeva, M.; Rebrova, O.; Gerasimova, K.; Asmolova, G.; Pankratyeva, L.; Degtyareva, E.; Ovsyannikov, D.

Browse all works by Soldatova, I.; Ignatyeva, V.; Avksentyeva, M.; Rebrova, O.; Gerasimova, K.; Asmolova, G.; Pankratyeva, L.; Degtyareva, E.; Ovsyannikov, D.